- Home
- CIFR vs BAX Comparison
CIFR vs BAX Comparison
Compare CIFR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIFR | BAX |
|---|---|---|
| Founded | 2021 | 1931 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.0B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | CIFR | BAX |
|---|---|---|
| Price | $22.36 | $22.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $24.91 | $21.00 |
| AVG Volume (30 Days) | ★ 23.1M | 6.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $12.29 | $1.96 |
| Revenue Next Year | $240.53 | $2.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $4.55 | $15.73 |
| 52 Week High | $30.14 | $29.35 |
Technical Indicators
Market Signals| Indicator | CIFR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 64.30 |
| Support Level | $13.48 | $19.04 |
| Resistance Level | $25.52 | $23.93 |
| Average True Range (ATR) | 2.34 | 0.65 |
| MACD | -0.52 | 0.05 |
| Stochastic Oscillator | 26.78 | 78.56 |
Price Performance
Historical ComparisonAbout CIFR Cipher Mining Inc.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.